Gallantt Ispat Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
GALLANTT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gallantt Ispat's board approved unaudited financial results for Q2 and H1 FY26 (ended September 30, 2025). Standalone revenue from operations rose to about Rs. 1,292.7 crore in Q2 from Rs. 1,012.8 crore a year earlier, roughly 27% YoY growth on the quarterly basis. Profit after tax jumped to about Rs. 87.2 crore in Q2 versus Rs. 48.9 crore last year (up ~78%), and H1 PAT grew to about Rs. 261 crore from Rs. 171 crore. The company also approved the sale of its entire stakes in two associates — Gallantt Medicity Devlopers (Rs. 7.80 crore) and Gallantt Lifespace Devlopers (Rs. 81.90 crore) — both to Gallantt Fincares Private Limited, a promoter group entity, for a combined ~Rs. 89.7 crore. Separately, the board approved setting up an 18 MW solar power plant in Gujarat at a cost of Rs. 48.25 crore, targeted to be operational by May 31, 2026.
Strong quarterly earnings beat on profit growth (PAT up ~78% YoY) is a positive signal for shareholders, supported by healthy operating cash flow. The two associate divestitures are related-party transactions with the promoter group, so minority shareholders should watch the sale valuations. The solar power investment adds ~Rs. 48 crore of capex but supports long-term cost efficiency in the steel and power business.